| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | OPEXA THERAPEUTICS EQUITY WARRANTS 03/13/201 | 500 | 0 | 0.00% | ||
| 2 | CHECK CAP LTD | 55,000 | 55,000 | 0.04% | ||
| 3 | GLOBEIMMUNE INC | 9,445 | 69,000 | 0.05% | SH | |
| 4 | TONIX PHARMACEUTICALS HOLDING | 14,400 | 91,000 | 0.07% | SH | |
| 5 | FATE THERAPEUTICS INC | 20,190 | 99,000 | 0.08% | SH | |
| 6 | CHEMBIO DIAGNOSTICS INC COM NEW | 26,287 | 106,000 | 0.08% | SH | |
| 7 | APTOSE BIOSCIENCES INC | 22,289 | 121,000 | 0.09% | ||
| 8 | CAS MED SYS INC | 100,000 | 134,000 | 0.10% | ||
| 9 | NANOSPHERE INC | 600,000 | 139,000 | 0.11% | SH | |
| 10 | TRANSITION THERAPEUTICS INC | 26,410 | 180,000 | 0.14% | ||
| 11 | ACTINIUM PHARMACEUTICALS INC | 90,000 | 222,000 | 0.17% | ||
| 12 | BOVIE MEDICAL CORP COM | 100,000 | 239,000 | 0.18% | ||
| 13 | LPATH INC | 111,884 | 276,000 | 0.21% | SH | |
| 14 | GENVEC INC | 100,000 | 295,000 | 0.23% | SH | |
| 15 | CUTERA INC COM | 23,490 | 303,000 | 0.23% | SH | |
| 16 | VENAXIS INC | 658,000 | 305,000 | 0.23% | SH | |
| 17 | GALENA BIOPHARMA INC | 250,000 | 348,000 | 0.27% | ||
| 18 | Aldeyra Therapeutics Inc | 35,000 | 356,000 | 0.27% | ||
| 19 | LUMENIS LTD | 31,072 | 372,000 | 0.29% | SH | |
| 20 | EPIZYME INC COM | 20,000 | 376,000 | 0.29% | ||
| 21 | AFFIMED N V COM | 62,500 | 394,000 | 0.30% | SH | |
| 22 | RTI SURGICAL HOLDINGS INC COM | 85,918 | 424,000 | 0.33% | SH | |
| 23 | KERYX BIOPHARMACEUTICALS INCORPORATED | 34,800 | 443,000 | 0.34% | SH | |
| 24 | MINERVA NEUROSCIENCES INC COM | 101,317 | 507,000 | 0.39% | ||
| 25 | CYNAPSUS THERAPEUTICS INC | 543,927 | 521,000 | 0.40% | SH | |
| 26 | INTERCEPT PHARMACEUTICALS INCORPORATED | 2,000 | 564,000 | 0.43% | SH | |
| 27 | COGENTIX MED INC | 353,181 | 593,000 | 0.46% | ||
| 28 | CHECK CAP LTD | 110,000 | 605,000 | 0.46% | ||
| 29 | Cynapsus Therapeutics Inc | 717,200 | 687,000 | 0.53% | ||
| 30 | CAREDX INC | 123,883 | 687,000 | 0.53% | SH | |
| 31 | Curis, Inc | 299,800 | 720,000 | 0.55% | SH | |
| 32 | UNIQURE NV | 30,000 | 730,000 | 0.56% | SH | |
| 33 | Exactech Inc | 31,636 | 811,000 | 0.62% | SH | |
| 34 | XENOPORT INC | 116,259 | 828,000 | 0.64% | SH | |
| 35 | ENCISION INC | 1,062,500 | 829,000 | 0.64% | SH | |
| 36 | NUVASIVE INC | 760,000 | 935,000 | 0.72% | PRN | |
| 37 | CARDICA INC | 1,486,004 | 936,000 | 0.72% | SH | |
| 38 | JOHNSON & JOHNSON | 9,400 | 946,000 | 0.73% | SH | |
| 39 | TANDEM DIABETES CARE INC COM | 76,340 | 963,000 | 0.74% | ||
| 40 | BLUEBIRD BIO INC COM | 8,000 | 966,000 | 0.74% | SH | |
| 41 | CYTRX CORP | 300,813 | 1,014,000 | 0.78% | SH | |
| 42 | SYNERON MEDICAL LTD | 90,947 | 1,126,000 | 0.86% | SH | |
| 43 | ZOGENIX INC | 853,700 | 1,170,000 | 0.90% | ||
| 44 | TARGACEPT INC | 465,293 | 1,382,000 | 1.06% | SH | |
| 45 | SPECTRANETICS CORP | 39,812 | 1,384,000 | 1.06% | SH | |
| 46 | ESSA Pharma | 250,000 | 1,422,000 | 1.09% | ||
| 47 | BIOCRYST PHARMACEUTICALS | 166,656 | 1,505,000 | 1.16% | SH | |
| 48 | Neothetics Inc | 186,807 | 1,534,000 | 1.18% | SH | |
| 49 | Ascendis Pharma | 93,541 | 1,623,000 | 1.25% | ||
| 50 | ZS PHARMA INC | 39,100 | 1,645,000 | 1.26% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001389933-15-000013, filed 2015.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.